DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

India Glycols Limited — Outcome of Board Meeting

NSE 2 hrs ago·12 Aug 2026, 11:34 am

India Glycols

India Glycols Limited has informed the stock exchanges about its financial results for the period ending June 30, 2026. This disclosure is a routine corporate update that provides investors with the company's performance data for the quarter.

This announcement is significant for retail investors as it offers a fresh look at the company's operational health and financial trajectory. By reviewing the earnings, investors can assess the company's current standing and make more informed decisions about their portfolio.

Investors should focus on the key performance metrics, such as revenue growth and profit margins, presented in the filing. Monitoring the company's future guidance and any commentary from management will be crucial to understanding its upcoming prospects.